views

Plant Health Care – peptide fungicide US approval, a “significant milestone”?

Plant Health Care (PHC) “is pleased to announce US Environmental Protection Agency commercial approval of its novel peptide fungicide, coded as PHC279” and that “Wilbur-Ellis Agribusiness, one of the largest U.S. retailers of agricultural products, is expected to commence sales of PHC279 within key US markets under the brand Obrona in 2023”. So what of a current more than 8.5% higher share price response to 11.4p?

views

Plant Health Care – argues revenue growth “strong performance”, BUT...

Plant Health Care (PHC) has updated emphasising “the company's revenue growth in the first half of 2020 is a strong performance, which demonstrates the merits of exposure to agriculture, as an essential industry” and “Covid-19 has had limited impact on the business to date”. The shares though are currently still at 9.625p, down from 15p+ in February...

NEWSFLOW

Plant Health Care (#PHC) – H1 loss on revenue up to $3.1m, retains “cautious” outlook

views

Plant Health Care – you were warned & now “delighted to have the support of shareholders”… as seeks to deliver a smaller investor screwing!

Early this month I noted announcements from Plant Health Care (PHC) which had helped the shares to 12.5p ramptastic and concluded I’d certainly wait and see on “well positioned” – and currently continue to avoid. Now (natch) “Placing and Subscription”…

NEWSFLOW

Plant Health Care (#PHC) – proposed minimum $4m placing & subscription at 8p per share, a 44% discount!

views

Plant Health Care – argues “significant” regulatory approval… but how ‘well positioned’?

Plant Health Care (PHC) has today followed two January announcements with another – which has currently helped the shares to 12.5p, a further approaching 9% higher…

views

Plant Health Care – warns & I thought it was to be “cash positive… within our existing cash reserves”?!...

Previously writing on agriculture biological products company Plant Health Care (PHC), in September it was “delighted”… but it’s an RNS Reach again & market seeing through it this time?. Now “Trading Update” – and the shares currently back at 7.5p, capitalising the company at circa £15.5 million, more than 12% lower on the day…

views

Plant Health Care – “delighted”… but it’s an RNS Reach again & market seeing through it this time?

Last month a “Progress with PREtec field trials in Brazil” announcement from Plant Health Care (PHC) saw the shares soar towards 9p. They had since slid back to 7.5p – and today a “Pilot production of PREtec peptides” announcement…

views

Plant Health Care – shares soar on ‘extremely encouraging’ field trial results… but beware, it’s an RNS Reach…

Plant Health Care (PHC) “is pleased to provide” an update on field trials of its PREtec peptide PHC279 for the control of Asian Soybean Rust in Brazil – and the shares have responded currently more than 50% higher, towards 9p…

views

Plant Health Care – sales warning, but still argues “very encouraged” & “confidence”. Really?

Updating last month on Plant Health Care (PHC), I concluded, with the shares at 10.1p,… “much to be achieved from the reported position - and also having noted previously what happened with some previous confidence from the company - I currently continue to avoid”. Now a near last minute before Christmas “Trading Statement”…